Free Trial
TSE:ACB

Aurora Cannabis Q2 2027 Earnings Results & Report

Aurora Cannabis logo
C$7.30 0.00 (0.00%)
As of 01:59 PM Eastern

Aurora Cannabis reported Q2 2027 earnings on November 5, 2026. The company reported EPS of C$0.05, while revenue was C$86.02 million.

Earnings Announcement Details

Quarter
Q2 2027
Report Date
Time
Before Market Opens

Aurora Cannabis EPS Results

Actual EPS
C$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 8 quarters

Aurora Cannabis Revenue Results

Actual Revenue
C$86.02 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Aurora Cannabis Q2 2027 Earnings FAQ

Aurora Cannabis (TSE:ACB) reported earnings of C$0.05 per share for Q2 2027. The report was announced on Thursday, November 5, 2026.

Aurora Cannabis reported revenue of C$86.02 million for Q2 2027.

Aurora Cannabis Earnings Headlines

The Withdrawal You'll Never See on Your Statement
A proposal circulating in Washington, dubbed the Mar-a-Lago Accord, calls for tariffs and currency pressure to deliberately weaken the US dollar, making American exports cheaper. For savers, a weaker dollar can quietly reduce purchasing power even if account balances stay the same. Bishop Gold Group's free 2026 Gold IRA Guide explains how physical gold can be held inside a retirement account, including a common rollover mistake that can trigger a taxable distribution.tc pixel
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Aurora Cannabis And 2 Other Canadian Healthcare Stocks To Own
See More Aurora Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aurora Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aurora Cannabis and other key companies, straight to your email.

About Aurora Cannabis

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

View Aurora Cannabis Profile